- Represented Advaxis Inc., a biopharmaceutical company developing immunotherapies, in a clinical collaboration and licensing deal with Amgen Inc. for a preclinical candidate involving $65 million in upfront cash and equity investment with $475 million in development, regulatory and sales milestones and tiered royalties on net sales.
- Negotiated a $100 million international technology transfer transaction for advanced medical devices.
- Negotiated joint development and license transactions for an advanced materials company.
- Handles technology transfer and licensing transactions for the commercialization of technologies, including wireless sensor networks, detection systems, consumer and electronics products, optics, medical devices, software and nanotechnology.
- Represented an Internet consumer business from its early stage through the successful sale of assets in connection with Internet transactions, advertising, data and IP issues.
- Resolved a multiforum patent dispute involving two international arbitration proceedings and a final U.S. district court judgment.
- Supervised copyright litigation and related remedies under the Digital Millennium Copyright Act on behalf of a major motion picture studio to stop the unauthorized use and copying of content on the Internet.
- Handles licensing and IP transactions for a global consumer goods company.
- Represented software licensees in multiple lawsuits involving approximately $50 million in settlements or verdicts to date.
- Manages and structures copyright licensing, publishing transactions and copyright disputes for the estate of a preeminent author and editorial cartoonist.
- Enforced and licensed “rights of publicity” for the library/foundation of a former U.S. President.
- Represents leading nanotechnology inventors/founders in a variety of technology transfer and emerging company transactions.
Jonathan M. Gordon
Retired Partner,
- Phone: +1 213 576 1165
- Email: jonathan.gordon@alston.com